DangerousContraindicated
Combining sertraline (an SSRI) with St. John's Wort creates a serious risk of serotonin syndrome, a potentially life-threatening condition. St. John's Wort inhibits serotonin reuptake and may also inhibit MAO, dramatically increasing synaptic serotonin when combined with an SSRI.
Recommendation: Do not take St. John's Wort with sertraline or any SSRI. This is a well-documented dangerous interaction with risk of serotonin syndrome (symptoms include agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle twitching, and hyperthermia).
SeriousContraindicated
5-HTP is a direct precursor to serotonin that bypasses the rate-limiting step in serotonin synthesis. When combined with sertraline's serotonin reuptake inhibition, 5-HTP can cause excessive serotonin accumulation and potentially trigger serotonin syndrome.
Recommendation: Do not combine 5-HTP with sertraline. The risk of serotonin syndrome is significant. If you are taking 5-HTP, inform your prescriber before starting any SSRI.
SeriousCaution
SAMe (S-adenosylmethionine) has demonstrated antidepressant properties and increases serotonergic, noradrenergic, and dopaminergic activity. When combined with sertraline, SAMe may excessively potentiate serotonergic signaling, increasing the risk of serotonin syndrome.
Recommendation: Use SAMe with sertraline only under direct medical supervision. Do not self-prescribe this combination. If prescribed together as adjunctive therapy, start SAMe at low doses and watch for signs of serotonin excess.
SeriousCaution
L-Tryptophan is the dietary amino acid precursor to serotonin. Supplemental tryptophan increases serotonin synthesis, and combined with sertraline's reuptake inhibition, can cause excessive serotonergic activity. Cases of serotonin syndrome have been reported with this combination.
Recommendation: Avoid supplemental L-tryptophan while taking sertraline. Dietary tryptophan from food is generally safe. If already taking both, discontinue L-tryptophan and inform your prescriber.
DangerousContraindicated
Concurrent use of SSRIs and tramadol significantly increases the risk of serotonin syndrome, a potentially life-threatening condition characterized by agitation, hyperthermia, tachycardia, and neuromuscular abnormalities.
Recommendation: Avoid concurrent use. If both are necessary, use the lowest effective doses with close monitoring for serotonin syndrome symptoms. Seek immediate medical attention for fever, agitation, or muscle rigidity.
SeriousCaution
Combining an SSRI with a tricyclic antidepressant increases the risk of serotonin syndrome and may elevate TCA blood levels due to CYP2D6 inhibition, increasing the risk of TCA toxicity including cardiac arrhythmias.
Recommendation: Generally avoid this combination. If clinically necessary, use reduced TCA doses with serum TCA level monitoring and ECG surveillance.
ModerateCaution
While SSRIs and lithium are commonly used together in treatment-resistant depression and bipolar disorder, the combination carries a modest risk of serotonin syndrome and lithium augments serotonergic neurotransmission.
Recommendation: This combination is often used intentionally under psychiatric supervision. Monitor for serotonin syndrome symptoms, especially when initiating or increasing SSRI dose. Therapeutic lithium level monitoring remains essential.
ModerateCaution
Sertraline is serotonergic. Rhodiola has preclinical monoamine and MAO-related findings, but direct human evidence for serotonin syndrome with Sertraline is limited. Combined use should be treated as a theoretical serotonergic-interaction risk, not as a proven prescription-MAOI-like contraindication.
Recommendation: Do not use Rhodiola to self-augment Sertraline. Discuss Rhodiola with the prescriber or pharmacist first, especially if other serotonergic agents are present, and seek care for serotonin-toxicity symptoms if both are used.
DangerousContraindicated
MDMA causes massive serotonin release by reversing the serotonin transporter (SERT), and sertraline blocks SERT — the same protein MDMA needs to function. Combining them can blunt MDMA's intended effect while still flooding the synapse with serotonin, producing potentially fatal serotonin syndrome with hyperthermia, seizures, and cardiovascular collapse. Cases in adolescents on SSRIs are a documented danger.
Recommendation: Do not combine MDMA with sertraline. If you are prescribed sertraline, treat MDMA as off-limits. Even after stopping sertraline, wait at least 1-2 weeks before any MDMA exposure.
ModerateCaution
Sertraline blocks the serotonin transporter and occupies postsynaptic 5-HT2A receptors over time, blunting psilocybin's intended psychedelic effect. Most psilocybin therapy trials require patients to be off SSRIs for several weeks before dosing. The combined serotonergic load also carries a theoretical risk of serotonin syndrome, though documented cases with classical psychedelics are rare.
Recommendation: Do not take psilocybin while on sertraline if you want a meaningful experience — the response will likely be blunted. If you have stopped sertraline, follow clinical-trial protocols and wait at least 2 weeks before psilocybin.
ModerateCaution
Sertraline depletes platelet serotonin stores and impairs platelet aggregation, raising bleeding risk by roughly 40-55% across observational studies. Fish oil (high-dose EPA/DHA) adds modest, dose-dependent antiplatelet activity. Combined use compounds bleeding risk, particularly with concurrent NSAIDs, aspirin, or anticoagulants.
Recommendation: Low-dose fish oil (1g/day or less) is usually fine alongside sertraline. Avoid high-dose fish oil (over 3g/day EPA+DHA) unless your prescriber agrees, and watch for unusual bruising, nosebleeds, or GI bleeding. Stop fish oil at least 7 days before surgery.
ModerateCaution
Sertraline depletes platelet serotonin and impairs aggregation, raising bleeding risk. Ginkgo biloba contains ginkgolides that inhibit platelet-activating factor (PAF) and have been linked to bleeding events. In a case series of psychotropic-herbal interactions, ginkgo combined with SSRIs accounted for 27% of documented complications, mostly bleeding.
Recommendation: Avoid Ginkgo biloba while taking sertraline. If you have already started both, watch for easy bruising, nosebleeds, blood in stool or urine, and stop Ginkgo 7-14 days before any planned surgery.
NutriStack